Literature DB >> 16317758

Long-term follow-up of childhood cancer survivors: future directions for clinical care and research.

Smita Bhatia1, Anna T Meadows.   

Abstract

Improvement in survival after childhood cancer has resulted in a growing population of childhood cancer survivors, causing the healthcare community to focus on providing appropriate care to the survivors, and addressing issues related to the etiology and prevention of long-term sequelae of cancer and its treatment. The overarching goal is to decrease the morbidity related to cancer treatment, and improve the overall quality of life, such that cancer survivors can successfully integrate back into society and lead productive lives. In order to achieve this goal, several issues need to be addressed, such as education of survivors and healthcare providers regarding the potential late effects; provision of standardized guidelines for appropriate follow-up of the survivors in a setting that is feasible and practical for the cancer survivor; ongoing communication between the cancer center that provided acute care for the patient and the healthcare facility providing follow-up care. Several challenges remain in addressing these issues, and will be the focus of this article.

Entities:  

Mesh:

Year:  2006        PMID: 16317758     DOI: 10.1002/pbc.20613

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  21 in total

1.  Health knowledge about symptoms of heart attack and stroke in adult survivors of childhood acute lymphoblastic leukemia.

Authors:  James G Gurney; Janet E Donohue; Kirsten K Ness; Maura O'Leary; Stephen P Glasser; K Scott Baker
Journal:  Ann Epidemiol       Date:  2007-07-27       Impact factor: 3.797

Review 2.  Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group.

Authors:  Gisela Michel; Renée L Mulder; Helena J H van der Pal; Roderick Skinner; Edit Bárdi; Morven C Brown; Janine Vetsch; Eva Frey; Rachael Windsor; Leontien C M Kremer; Gill Levitt
Journal:  J Cancer Surviv       Date:  2019-08-08       Impact factor: 4.442

Review 3.  Challenges and opportunities in childhood cancer drug development.

Authors:  Robin E Norris; Peter C Adamson
Journal:  Nat Rev Cancer       Date:  2012-10-11       Impact factor: 60.716

4.  Cancer-related follow-up care among Hispanic and non-Hispanic childhood cancer survivors: The Project Forward study.

Authors:  Joel E Milam; Kathleen Meeske; Rhona I Slaughter; Sandra Sherman-Bien; Anamara Ritt-Olson; Aura Kuperberg; David R Freyer; Ann S Hamilton
Journal:  Cancer       Date:  2014-10-23       Impact factor: 6.860

Review 5.  Surviving childhood cancer: the impact on life.

Authors:  Robert E Goldsby; Denah R Taggart; Arthur R Ablin
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

6.  The Children's Oncology Group's 2013 five year blueprint for research.

Authors:  Peter C Adamson
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

7.  Assessment of selection bias in clinic-based populations of childhood cancer survivors: a report from the childhood cancer survivor study.

Authors:  Kirsten K Ness; Wendy Leisenring; Pam Goodman; Toana Kawashima; Ann C Mertens; Kevin C Oeffinger; Gregory T Armstrong; Leslie L Robison
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

Review 8.  Imaging in early phase childhood cancer trials.

Authors:  Peter C Adamson
Journal:  Pediatr Radiol       Date:  2008-12-16

Review 9.  Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children's Oncology Group.

Authors:  Lindsay A Renfro; Lingyun Ji; Jin Piao; Arzu Onar-Thomas; John A Kairalla; Todd A Alonzo
Journal:  JCO Precis Oncol       Date:  2019-10-24

10.  Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study.

Authors:  Shoshana M Rosenberg; Chaya S Moskowitz; Jennifer S Ford; Tara O Henderson; A Lindsay Frazier; Lisa R Diller; Melissa M Hudson; Annette L Stanton; Joanne F Chou; Stephanie Smith; Wendy M Leisenring; Ann C Mertens; Cheryl L Cox; Paul C Nathan; Kevin R Krull; Leslie L Robison; Kevin C Oeffinger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-24       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.